1. New EU FP7 calls Cornelia Thomas
Senior Research Funding Advisor Research Funding Services, Viikki Campus BI, BioCentre 1A, room phone:+358 (0)

2. Remit International grant support for BI staff
European Programmes - Focus on ERC and other FP7
Other international funders
Funding opportunities alerts and search
Application documents, briefings and guidance
Budgeting support
Proposal edit
Submission support
Contract negotiation support

3. FP7 Activities 2012/13 deadlines draft workprogrammes
January February
March April
May June
July August
September
October
November December
submission support
draft workprogrammes
alerts, advice, briefings
proposal preparation
proposal support
partner-searches,
consortium building
calls
advice
alerts

4. Funding Opportunities
FP7 Knowledge Based BioEconomy (KBBE-FAFB)
Call opens July 2012
Deadlines October-November (tbc) 2012
DRAFT topics!
plant health and crop protection (cereals, biol. control agents)
animal health (viral vector borne diseases, China)
sources of biomass and bioproducts (plants)
‘Omics’ technologies
Industrial biotechnology (biocatalysts)
Biorefinery
Environmental biotechnology
Emerging trends in biotechnology (bioinspired materials and processes, synthetic biology)
KBBE gap analysis
Area Enabling research
Main line 1.1: 'Omics technologies', systems biology and other basic plant sciences
-beneficial) (soil) microorganisms and the communication between those and the plant
biological/genetic basis of processes leading to increased productivity, resource efficiency and tolerance to biotic and abiotic stresses
genomic resources for crops of strategic importance
(molecular) characterisation and phenotyping of complex traits for a wide range of conditions and crops
genomic, genetic and bioinformatic resources
Main line 1.2: 'Omics technologies', systems biology and other basic sciences in farm animals
- Bioinformatics
- Systems biology
- Immunology
- Epigenetics and systems biology
- Host-pathogen interaction, identification of protective antigens in complex pathogens (bacteria, parasites)
- Cutting edge vaccinology platform
"One Flu": permanent observatory for influenza viruses; develop a platform for real time data analysis; model for other pathogens
Main line 1.4: Novel technologies for agricultural practices
Multilevel phenotyping tools - linking genetic information to traits and to environmental/management conditions
low-cost technology for small-scale farmer; e.g. for weed management and the physical control of pests
Area Increased sustainability of all production systems (agriculture, forestry, fisheries and aquaculture); plant health and crop protection
Main line 2.5: Increased plant resource efficiency; adaptation of plants, crops and forest trees to biotic and abiotic stress
- uptake of nutrients by trees/forests (nutrient sending, signalling, transport and primary metabolism) and their responses to stress (including complex interactions between soil, water, nutrients and root growth)
Main line 2.6: Plant health & Plant protection
reduction of pesticide use (both at plant and farm levels),
disease control e.g. soil-borne pathogens)
weed control and suppression.
pests and pathogens affecting specific crops, such as cereals, fruit trees and horticultural species.
Area Optimised animal health, production and welfare across agriculture, fisheries and aquaculture
Main line 3.1: Animal health and non food-borne zoonoses
- Addressing animal diseases from the production systems perspective;- Equidae
Area Novel sources of biomass and bioproducts
Main line 1: Enhanced metabolic pathways for novel bioproducts
bioactivities
metabolic potential of terrestrial plants,
metabolic engineering
Main line 2: Improving the production of plants for biomaterials and biofuels
to plants cultivated in small areas for their secondary metabolites which are used for the production of fine chemicals or specialty products (e.g. aromatic or medicinal plants)
Main line 3: Prospecting the biological diversity for the production of commercially valuable compounds
Bioprospecting
novel industrial applications (cosmetics, insecticides
Area Industrial biotechnology: novel high added-value bio-products and bio-processes
Main line 1: Novel and improved biocatalysts
improved versions of enzymes with known function and completely novel enzymes
new biocatalysts and the optimisation of the biocatalyst with biocatalytic process design.
Progress in the understanding of the molecular mechanism of enzyme actions
Main line 2: Pathway engineering for novel molecules and functions
- metabolic pathway engineering have a synergistic effect on the progress of synthetic biology - "a la carte" fuels and chemicals.
Main line 3: Optimising multiphase/multistep bioreactors
Multidisciplinary Bioprocess development
Main line 4: Novel and robust production micro-organisms for industrial processes
robust and flexible microbes capable of processing complex feedstocks
producing an increasing number of chemical products in a single step
new or improved industrial hosts.
Microbial stress under industrial conditions, pH, temperature, presence of toxic compounds, solvents
Area Biorefinery
Main line 1: By-products of biomass-based industries into bioproducts
biowaste streams for industrial applications
closed-loop systems
Area Environmental biotechnology
Main line 3: Microbial diversity and metagenomics
greening the industrial processes
novel organisms and enzymes suitable for industrial applications
Area Emerging trends in biotechnology
Main line 1: Nano-biotechnologies
-biomimetic and bioinspiration materials
Main line 3: Synthetic biology
minimal cell,
robust biomolecular circuits, modelling and computational design, SB databases and information systems).
potential applications of synthetic biology (e.g. applications in health sector, environment, energy etc.)
Systems biology
_______________________________________________________________________________
HEALTH Development of imaging technologies for therapeutic interventions in rare diseases HEALTH Safety and efficacy of therapeutic vaccines HEALTH : Development of alternative in vitro, analytical, immunochemical, and other test methods for quality control of vaccines HEALTH Controlling differentiation and proliferation in human stem cells intended for therapeutic use. HEALTH : Functional validation in animal and cellular models of genetic determinants of diseases and ageing processes. HEALTH : High impact research initiative on metagenomics for personalised medicine approaches HEALTH : Prospective data collection and Comparative Effectiveness Research for traumatic brain injury (TBI). HEALTH : Development of more effective imaging tools for diagnosis, monitoring and management of psychiatric disorders HEALTH : Innovation in vaccines HEALTH : Novel antimicrobials HEALTH : Stratified approaches for pathogen-host interactions Health : Emerging infectious diseases in Central- and Eastern Europe Health : Drug development for parasitic diseases HEALTH : Investigator-driven treatment trials on advanced therapies to combat metastases in patients with solid cancer HEALTH : Strengthening the cancer patient's immune system. HEALTH Discovery research to reveal novel targets for cardiovascular disease treatment

5. Funding Opportunities
FP7 Health
Call opens July 2012
Deadlines 25 September & 2 October 2012
DRAFT topics!
Imaging technologies
Vaccines
Stem cells
Antimicrobial drug resistance
Metagenomics - Personalised medicines
Genetic determinants of disease and ageing
Cancer
Cardiovascular disease
Traumatic brain injury
Parasitic diseases
Osasto / Henkilön nimi / Esityksen nimi

6. Funding Opportunities
ERC (note: structure and timing of calls will change)
- Synergy Grants Deadline January 2013 (tbc)
- Advanced Grants Deadline November 2012 (tbc)
- Starting Grants Deadline October 2012 (tbc)
- Consolidator Grants Deadline February 2013 (tbc)
FP7 Marie Curie*
- Career Integration Grant Deadline 18 September 2012
- Fellowships Deadline 16 August 2012
- Initial Training Networks Deadline 22 November 2012 (tbc)
- Industry-Academia Partnerships and Pathways Deadline 15 January (tbc)
- International Research Staff Exchange Scheme Deadline 17 January 2013 (tbc)
_______________________________________________________________________________________
*Marie Curie Support Katariina Vainio-Mattila
Tel ,

7. Get involved Consortium member Cooperation Host Marie Curie
Applicant ERC
Evaluator all of the above
The best way to gain insight into European Programmes is to act as evaluator. It is noticeable that there are less ‘Finns’ compared to other Nordic nations. I would like to strongly encourage you to join the database of evaluators for FP7.
Register here:
Osasto / Henkilön nimi / Esityksen nimi

8. Horizon 2020 Implemeting flagship initiative ’Innovation Union’
Designed to bring more good ideas to market
Major simplification through a single set of rules.
Combining all research and innovation funding currently provided through
the Framework Programmes for Research and Technical Development (FP7)
the innovation related activities of the Competitiveness and Innovation Framework Programme (CIP)
the European Institute of Innovation and Technology (EIT).
Osasto / Henkilön nimi / Esityksen nimi

9. Horizon 2020 - Key Objectives
 Excellent Science
ERC
Future and Emerging Technologies (FET)
Marie Curie Actions
Research Infrastructures
Competitive Industries
Information and Communication Technologies
Nanotechnologies, advanced Materials, Production Technologies
Biotechnology
Space Technologies
Innovation in SMEs
Access to Risk Finance
Better Society - Challenges
Health, demographic change and wellbeing
Food security, sustainable agriculture, marine/maritime research, bio-economy
Climate action, resource efficiency and raw materials
Smart, green and integrated transport
Inclusive, innovative and secure societies
Secure, clean and efficient energy